Evidence map›Paper›PMID 24092382›Full record

ReviewTransplantation2014

Regulatory myeloid cells in transplantation.

Brian R Rosborough, Dàlia Raïch-Regué, Heth R Turnquist, Angus W Thomson

Abstract readEditorialReview
In one paragraph

Review in Transplantation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Genetic in situ engineering of myeloid regulatory cells controls inflammation in autoimmunity.Journal of controlled release : official journal of the Controlled Release Society · 2021
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Renal Allograft Survival in Nonhuman Primates Infused With Donor Antigen-Pulsed Autologous Regulatory Dendritic Cells.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2017
    Article
  16. Article
  17. In Vivo Mobilization and Functional Characterization of Nonhuman Primate Monocytic Myeloid-Derived Suppressor Cells.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2016
    Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Brian R Rosborough1 Thomas E. Starzl Transplantation Institute, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA. 2 Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA. 3 Address correspondence to: Angus W. Thomson, Ph.D., D.Sc., Departments of Surgery and Immunology, University of Pittsburgh School of Medicine, Thomas E. Starzl Transplantation Institute, 200 Lothrop Street, Biomedical Science Tower W1540, Pittsburgh, PA 15213.
Dàlia Raïch-Regué
Heth R Turnquist
Angus W Thomson
H.C. Starck (Germany) · DEUniversity of Pittsburgh · US

Funding

RHESUS MONKEY DENDRITIC CELLS FOR TRANSPLANT TOLERANCEU01AI051698 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI THOMSON, ANGUS W · 2002 to 2011
$4.9M
Interdisciplinary Training in Transplantation BiologyT32AI074490 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Angus W Thomson · 2007 to 2026
$4.2M
Liver Antigen - Presenting Cells in Hepatic Injury and TransplantationP01AI081678 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI THOMSON, ANGUS W · 2009 to 2010
$2.8M
Dendritic Cells, Rapamycin and Transplant ToleranceR01AI067541 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI THOMSON, ANGUS W · 2007 to 2010
$1.7M
Influence of ST2 and IL-33 on cardiac allograft vasculopathy and outcomeR00HL097155 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI TURNQUIST, HETH R · 2011 to 2013
$723k
Influence of ST2 and IL-33 on cardiac allograft vasculopathy and outcomeK99HL097155 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI TURNQUIST, HETH R · 2009 to 2010
$174k
NHLBI NIH HHS K99 HL097155NHLBI NIH HHS R00 HL097155NHLBI NIH HHS R00HL097155NIAID NIH HHS P01 AI081678NIAID NIH HHS P01AI81678NIAID NIH HHS R01 AI067541NIAID NIH HHS R01AI67541NIAID NIH HHS T32AI07449NIAID NIH HHS T32 AI074490NIAID NIH HHS U01 AI051698NIAID NIH HHS U01AI51698
6 · The paper itself

Abstract

Regulatory myeloid cells (RMC) are emerging as novel targets for immunosuppressive (IS) agents and hold considerable promise as cellular therapeutic agents. Herein, we discuss the ability of regulatory macrophages, regulatory dendritic cells, and myeloid-derived suppressor cells to regulate alloimmunity, their potential as cellular therapeutic agents, and the IS agents that target their function. We consider protocols for the generation of RMC and the selection of donor- or recipient-derived cells for adoptive cell therapy. Additionally, the issues of cell trafficking and antigen (Ag) specificity after RMC transfer are discussed. Improved understanding of the immunobiology of these cells has increased the possibility of moving RMC into the clinic to reduce the burden of current IS agents and to promote Ag-specific tolerance. In the second half of this review, we discuss the influence of established and experimental IS agents on myeloid cell populations. IS agents believed historically to act primarily on T cell activation and proliferation are emerging as important regulators of RMC function. Better insights into the influence of IS agents on RMC will enhance our ability to develop cell therapy protocols to promote the function of these cells. Moreover, novel IS agents may be designed to target RMC in situ to promote Ag-specific immune regulation in transplantation and to usher in a new era of immune modulation exploiting cells of myeloid origin.

Indexed as

Adoptive TransferAnimalsAntigensCell Culture TechniquesCell MovementCell SurvivalCell TransplantationDendritic CellsHumansImmune ToleranceImmunosuppression TherapyImmunosuppressive AgentsImmunotherapyInflammationLeukocytes, MononuclearMacrophagesAntigensImmunosuppressive Agents

Identifiers

PMID24092382
PMCPMC3944083
OpenAlexW2049451888

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.